resolver

Sarrazin, C., Berg, T., Ross, R.S., Schirmacher, P., Wedemeyer, H., Neumann, U.,
Schmidt, H.H., Spengler, U., Wirth, S., Kessler, H.H., Peck-Radosavljevic, M.,
Ferenci, P., Vogel, W., Moradpour, D., Heim, M., Cornberg, M., Protzer, U., Manns,
M.P., Fleig, W.E., Dollinger, M.M., Zeuzem, S. (2010). Prophylaxis, diagnosis and
therapy of hepatitis C virus (HCV) infection: the German guidelines on the
management of HCV infection. Z Gastroenterol. 48, 289-351
Sarrazin C, Berg T, Cornberg M, Dollinger M, Ferenci P, Hinrichsen H, Klinker H,
Kraus M, Manns M, Mauss S, Peck-Radosavljevic M, Schmidt H, Spengler U,
Wedemeyer H, Wirth S, Zeuzem S. (2012). Expert opinion on boceprevir- and
telaprevir-based triple therapies of chronic hepatitis C. Z Gastroenterol. 50, 57-72
Sarrazin C, Berg T, Buggisch P, Dollinger MM, Hinrichsen H, Hofer H, Hüppe D,
Manns MP, Mauss S, Petersen J, Simon KG, van Thiel I, Wedemeyer H, Zeuzem S.
(2015). S3 guideline hepatitis C addendum. Z Gastroenterol. 53, 320-34
Schellekens, H., Dinan, T.G., Cryan, J.F. (2010). Lean mean fat reducing "ghrelin"
machine: hypothalamic ghrelin and ghrelin receptors as therapeutic targets in
obesity. Neuropharmacology 58, 2-16
Schirra, J., Houck, P., Wank, U., Arnold, R., Göke, B., Katschinski, M. (2000).
Effects of glucagon-like peptide-1(7-36)amide on antro-pyloro-duodenal motility in
the interdigestive state and with duodenal lipid perfusion in humans. Gut 46, 622-631
Seeff, L.B., Hollinger, F.B., Alter, H.J., Wright, E.C., Cain, C.M., Buskell, Z.J.,
Ishak, K.G., Iber, F.L., Toro, D., Samanta, A., Koretz, R.L., Perrillo, R.P., Goodman,
Z.D., Knodell, R.G., Gitnick, G., Morgan, T.R., Schiff, E.R., Lasky, S., Stevens, C.,
Vlahcevic, R.Z., Weinshel, E., Tanwandee, T., Lin, H.J., Barbosa, L. (2001). Longterm
mortality and morbidity of transfusion-associated non-A, non-B, and type C
hepatitis: A National Heart, Lung, and Blood Institute collaborative study.
Hepatology 33, 455-463
Seeff, L.B., Hoofnagle, J.H. (2002). National Institutes of Health Consensus
Development Conference: management of hepatitis C: 2002. Hepatology 36, 1-2
82